Details:

Personal Author:
Heneine, Walid ; Thompson, Melanie ; Smith, Dawn K. ; Iskander, John K. ; Thorpe, Phoebe ; ... More +
Heneine, Walid ; Thompson, Melanie ; Smith, Dawn K. ; Iskander, John K. ; Thorpe, Phoebe ; Laird, Susan Less -
Corporate Authors:
Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention
.
Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention
. Less -
Description:
An estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States annually. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended for high-risk populations to reduce their risk of becoming infected with HIV. PrEP includes daily medication and routine follow-up. When used consistently, PrEP is shown to reduce the risk of HIV infection. If delivered effectively and used in combination with other proven prevention methods, PrEP may play a significant role in helping to address the HIV epidemic in the United States.

Presented by: Walid Heneine, PhD, 
Surveillance, Antiretroviral Prophylaxis and Drug Resistance Team Lead
, Division of HIV/AIDS Prevention, 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC [
“HIV Pre-exposure Prophylaxis (PrEP) Preclinical Research in Animal Models”]; Melanie Thompson, MD
, Founder and Principal Investigator, 
AIDS Research Consortium of Atlanta
 [“Evolving Evidence from Clinical Trials of HIV Pre-Exposure Prophylaxis”]; Dawn Smith, MD, MS, MPH, 
Biomedical Interventions Activity Lead, Prevention with Negatives Team
, Division of HIV/AIDS Prevention, 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
 [“Program and Policy Challenges for Delivery of PrEP”].

Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; 
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; 
Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds.


Subject:
[+]
Anti-HIV Agents/therapeutic Use
HIV Infections/epidemiology
HIV Infections/prevention & Control
Pre-Exposure Prophylaxis
Truvada

Source:
Public health grand rounds ; 2014 April 22
Document Type:
Presentation
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:33089d2ac6d809f6ede935aab655e93efb8be02bb3a5ced4e95d6dcc85f807ac
File Type:

Supporting Files

• No Additional Files

More +